Literature DB >> 14557054

Transcriptionally targeted gene therapy to detect and treat cancer.

Lily Wu1, Mai Johnson, Makoto Sato.   

Abstract

The greatest challenge in cancer treatment is to achieve the highest levels of specificity and efficacy. Cancer gene therapy could be designed specifically to express therapeutic genes to induce cancer cell destruction. Cancer-specific promoters are useful tools to accomplish targeted expression; however, high levels of gene expression are needed to achieve therapeutic efficacy. Incorporating an imaging reporter gene in tandem with the therapeutic gene will allow tangible proof of principle that gene expression occurs at the correct location and at a sufficient level. Gene-based imaging can advance cancer detection and diagnosis. By combining the cancer-targeted imaging and therapeutic strategies, the exciting prospect of a 'one-two punch' to find hidden, disseminated cancer cells and destroy them simultaneously can potentially be realized.

Entities:  

Mesh:

Year:  2003        PMID: 14557054      PMCID: PMC2821220          DOI: 10.1016/j.molmed.2003.08.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  69 in total

Review 1.  Integrated, molecular engineering approaches to develop prostate cancer gene therapy.

Authors:  Lily Wu; Makoto Sato
Journal:  Curr Gene Ther       Date:  2003-10       Impact factor: 4.391

2.  Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Authors:  M E Black; T G Newcomb; H M Wilson; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

3.  Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.

Authors:  D G Johnson; K Ohtani; J R Nevins
Journal:  Genes Dev       Date:  1994-07-01       Impact factor: 11.361

4.  A novel role for site-specific recombination in maintenance of bacterial replicons.

Authors:  S Austin; M Ziese; N Sternberg
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

5.  The demonstration of alpha lactalbumin in human breast carcinomas.

Authors:  R A Walker
Journal:  J Pathol       Date:  1979-09       Impact factor: 7.996

6.  Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.

Authors:  K J Johnson; K-W Peng; C Allen; S J Russell; E Galanis
Journal:  Gene Ther       Date:  2003-05       Impact factor: 5.250

7.  Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.

Authors:  T Tanaka; F Kanai; S Okabe; Y Yoshida; H Wakimoto; H Hamada; Y Shiratori; K Lan; M Ishitobi; M Omata
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

Review 8.  Imaging of angiogenesis: from microscope to clinic.

Authors:  Donald M McDonald; Peter L Choyke
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

9.  Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.

Authors:  C A Richards; E A Austin; B E Huber
Journal:  Hum Gene Ther       Date:  1995-07       Impact factor: 5.695

10.  Interrogating androgen receptor function in recurrent prostate cancer.

Authors:  Liqun Zhang; Mai Johnson; Kim H Le; Makoto Sato; Romyla Ilagan; Meera Iyer; Sanjiv S Gambhir; Lily Wu; Michael Carey
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  13 in total

1.  Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.

Authors:  Makoto Sato; Mai Johnson; Liqun Zhang; Baohui Zhang; Kim Le; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

2.  Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.

Authors:  Christopher M Hine; Andrei Seluanov; Vera Gorbunova
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

3.  Configurations of a two-tiered amplified gene expression system in adenoviral vectors designed to improve the specificity of in vivo prostate cancer imaging.

Authors:  M Sato; M L Figueiredo; J B Burton; M Johnson; M Chen; R Powell; S S Gambhir; M Carey; L Wu
Journal:  Gene Ther       Date:  2008-02-28       Impact factor: 5.250

4.  Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma.

Authors:  Dingyuan Zeng; Jiajing Lin; Hongying He; Guangping Tan; Ying Lan; Fuyan Jiang; Shuting Sheng
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

5.  Regulation of Rad51 promoter.

Authors:  Christopher M Hine; Hongjie Li; Li Xie; Zhiyong Mao; Andrei Seluanov; Vera Gorbunova
Journal:  Cell Cycle       Date:  2014-04-29       Impact factor: 4.534

6.  Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.

Authors:  Ju Hui Park; Kwang Il Kim; Kyo Chul Lee; Yong Jin Lee; Tae Sup Lee; Wee Sup Chung; Sang Moo Lim; Joo Hyun Kang
Journal:  Cancer Biother Radiopharm       Date:  2014-12-29       Impact factor: 3.099

7.  Use of the Rad51 promoter for targeted anti-cancer therapy.

Authors:  Christopher M Hine; Andrei Seluanov; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

8.  Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma.

Authors:  Yufang Zuo; Jiangxue Wu; Zumin Xu; Shiping Yang; Haijiao Yan; Li Tan; Xiangqi Meng; Xiaofang Ying; Ranyi Liu; Tiebang Kang; Wenlin Huang
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

9.  Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Czerniak; Tally Levy; Smadar Amiur; Jennifer Gallula; Imad Matouk; Rasha Abu-lail; Vladimir Sorin; Tatiana Birman; Nathan de Groot; Abraham Hochberg; Patricia Ohana
Journal:  J Transl Med       Date:  2009-08-06       Impact factor: 5.531

10.  Structural complementation of the catalytic domain of pseudomonas exotoxin A.

Authors:  Erin L Boland; Crystal M Van Dyken; Rachel M Duckett; Andrew J McCluskey; Gregory M K Poon
Journal:  J Mol Biol       Date:  2013-11-08       Impact factor: 6.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.